✦ LIBER ✦

Tissue Microarray Validation of Epidermal Growth Factor Receptor and SALL2 in Synovial Sarcoma with Comparison to Tumors of Similar Histology

✍ Scribed by Torsten O. Nielsen; Forrest D. Hsu; John X. O'Connell; C. Blake Gilks; Poul H.B. Sorensen; Sabine Linn; Robert B. West; Chih Long Liu; David Botstein; Patrick O. Brown; Matt van de Rijn

Book ID: 117021687
Publisher: American Society for Investigative Pathology
Year: 2003
Tongue: English
Weight: 629 KB
Volume: 163
Category: Article
ISSN: 0002-9440
DOI: 10.1016/s0002-9440(10)63502-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Human epidermal growth factor receptor 1

Human epidermal growth factor receptor 1 (EGFR) expression was not associated with gene amplification but intimately assoclated with HER2 gene amplification and protein expression in tissue microarray of clinical breast cancers

✍ S.K. Ahn; Gwak; K. Park; J. Kim; H. Park; S. Han; S.K. Ahn 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Phase I Active Immunotherapy With Combin

Phase I Active Immunotherapy With Combination of Two Chimeric, Human Epidermal Growth Factor Receptor 2, B-Cell Epitopes Fused to a Promiscuous T-Cell Epitope in Patients With Metastatic and/or Recurrent Solid Tumors

✍ Kaumaya, P. T.P.; Foy, K. C.; Garrett, J.; Rawale, S. V.; Vicari, D.; Thurmond, 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 217 KB

A phase I pharmacokinetic (PK) and seria

A phase I pharmacokinetic (PK) and serial tumor and skin pharmacodynamic (PD) study of weekly, every 2 weeks or every 3 weeks 1-hour (h) infusion EMD72000, an humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients (p) with advanced tumors known to overexpress the EGFR

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 256 KB